The time to certify pediatric urologists has arrived A. Barry Belman Invited Commentary Pages: 423 - 423
Methodologic shortcomings inherent in a post-hoc analysis David R. Staskin Clinical Trials Report Pages: 431 - 433
Incidence and prevalence of overactive bladder Eric S. RovnerAlan J. Wein OriginalPaper Pages: 434 - 438
Advances in drug delivery: Improved bioavailability and drug effect Roger R. DmochowskiDavid R. Staskin OriginalPaper Pages: 439 - 444
Overactive bladder in the male patient: Bladder, outlet, or both? Khaled F. Abdel-AzizGary E. Lemack OriginalPaper Pages: 445 - 451
Overactive bladder in the female patient: The role of estrogens Dudley RobinsonLinda Cardozo OriginalPaper Pages: 452 - 457
Conservative therapy for overactive bladder: Pelvic floor exercises Christina KwonPeter K. Sand OriginalPaper Pages: 458 - 462
PNU-83757: A new agent for the treatment of erectile dysfunction Culley C. Carson Clinical Trials Report Pages: 465 - 466
Combination therapy for erectile dysfunction: Where we are and what’s in the future Ajay NehraHaluk Kulaksizoglu OriginalPaper Pages: 467 - 470
Topical agents and erectile dysfunction: Is there a place? Ronald L. YapKevin T. McVary OriginalPaper Pages: 471 - 476
Vasoconstriction and vasodilation in erectile physiology Thomas M. Mills OriginalPaper Pages: 477 - 483
Female sexual dysfunction: State of the art Aristotelis G. AnastasiadisLaurent SalomonRidwan Shabsigh OriginalPaper Pages: 484 - 491
The etiology, diagnosis, and treatment of priapism: Review of the American Foundation for Urologic Disease Consensus Panel report Hossein Sadeghi-NejadAllen D. Seftel OriginalPaper Pages: 492 - 498